Evidence map›Paper›PMID 35177825›Full record

ArticleMolecular psychiatry2022

Translational profiling of mouse dopaminoceptive neurons reveals region-specific gene expression, exon usage, and striatal prostaglandin E2 modulatory effects.

Enrica Montalban, Albert Giralt, Lieng Taing, Evelien H S Schut, Laura F Supiot, Laia Castell, Yuki Nakamura, Benoit de Pins, Assunta Pelosi, Laurence Goutebroze and 16 more

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. The sodium leak channel NALCN in Drd2Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 8 institutions in 7 countries.

Enrica MontalbanInserm UMR-S 1270, Paris, France.
Albert GiraltInserm UMR-S 1270, Paris, France.ORCID http://orcid.org/0000-0001-5334-0963
Lieng TaingInserm UMR-S 1270, Paris, France.
Evelien H S SchutDepartment of Translational Neuroscience, Brain Center, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
Laura F SupiotDepartment of Translational Neuroscience, Brain Center, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.
Laia CastellIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.
Yuki NakamuraInserm UMR-S 1270, Paris, France.
Benoit de PinsInserm UMR-S 1270, Paris, France.ORCID http://orcid.org/0000-0002-6779-8446
Assunta PelosiInserm UMR-S 1270, Paris, France.
Laurence GoutebrozeInserm UMR-S 1270, Paris, France.
Pola TuduriIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.
Wei WangLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, USA.
Katrina Daila NeiburgaBabraham Institute, Cambridge, UK.ORCID http://orcid.org/0000-0002-4731-7596
Letizia VestitoBabraham Institute, Cambridge, UK.ORCID http://orcid.org/0000-0003-0008-936X
Julien CastelUniversité de Paris, CNRS, Unité de Biologie Fonctionnelle et Adaptative, Paris, France.ORCID http://orcid.org/0000-0003-4309-701X
Serge LuquetUniversité de Paris, CNRS, Unité de Biologie Fonctionnelle et Adaptative, Paris, France.ORCID http://orcid.org/0000-0001-8668-6645
Angus C NairnDepartment of Psychiatry, Yale School of Medicine, Connecticut Mental Health Center, New Haven, CT, USA.
Denis HervéInserm UMR-S 1270, Paris, France.
Nathaniel HeintzLaboratory of Molecular Biology, Howard Hughes Medical Institute, The Rockefeller University, New York, NY, USA.
Claire MartinUniversité de Paris, CNRS, Unité de Biologie Fonctionnelle et Adaptative, Paris, France.
Paul GreengardLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, USA.
Emmanuel ValjentIGF, CNRS, INSERM, University of Montpellier, Montpellier, France.ORCID http://orcid.org/0000-0002-1034-606X
Frank J MeyeDepartment of Translational Neuroscience, Brain Center, UMC Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID http://orcid.org/0000-0002-4730-2474
Nicolas GambardellaaSciStance Ltd, Great Chesterford, UK.
Jean-Pierre RoussarieLaboratory of Molecular and Cellular Neuroscience, The Rockefeller University, New York, NY, USA. jproussa@bu.edu.ORCID http://orcid.org/0000-0003-2644-6046
Jean-Antoine GiraultInserm UMR-S 1270, Paris, France. jean-antoine.girault@inserm.fr.ORCID http://orcid.org/0000-0002-7900-1705
Inserm · FRCentre National de la Recherche Scientifique · FRUtrecht University · NLBabraham Institute · GBRockefeller University · USBoston University · USConnecticut Mental Health Center · USHoward Hughes Medical Institute · US

Funding

Yale/NIDA Neuroproteomics Research CenterP30DA018343 · NIDA · YALE UNIVERSITY · PI Marina R Picciotto · 2004 to 2026
$37.1M
Cell-type Specific Psychostimulant Effects on the Neuronal TranslatomeR21DA040454 · NIDA · YALE UNIVERSITY · PI NAIRN, ANGUS C. · 2016 to 2017
$368k
Biotechnology and Biological Sciences Research Council BB/P013384/1Biotechnology and Biological Sciences Research Council BB/P013406/1Biotechnology and Biological Sciences Research Council BB/P013414/1NIDA NIH HHS P30 DA018343NIDA NIH HHS R21 DA040454
6 · The paper itself

Abstract

Forebrain dopamine-sensitive (dopaminoceptive) neurons play a key role in movement, action selection, motivation, and working memory. Their activity is altered in Parkinson's disease, addiction, schizophrenia, and other conditions, and drugs that stimulate or antagonize dopamine receptors have major therapeutic applications. Yet, similarities and differences between the various neuronal populations sensitive to dopamine have not been systematically explored. To characterize them, we compared translating mRNAs in the dorsal striatum and nucleus accumbens neurons expressing D1 or D2 dopamine receptor and prefrontal cortex neurons expressing D1 receptor. We identified genome-wide cortico-striatal, striatal D1/D2 and dorso/ventral differences in the translating mRNA and isoform landscapes, which characterize dopaminoceptive neuronal populations. Expression patterns and network analyses identified novel transcription factors with presumptive roles in these differences. Prostaglandin E2 (PGE2) was a candidate upstream regulator in the dorsal striatum. We pharmacologically explored this hypothesis and showed that misoprostol, a PGE2 receptor agonist, decreased the excitability of D2 striatal projection neurons in slices, and diminished their activity in vivo during novel environment exploration. We found that misoprostol also modulates mouse behavior including by facilitating reversal learning. Our study provides powerful resources for characterizing dopamine target neurons, new information about striatal gene expression patterns and regulation. It also reveals the unforeseen role of PGE2 in the striatum as a potential neuromodulator and an attractive therapeutic target.

Indexed as

DinoprostoneMisoprostolAnimalsCorpus StriatumDopamineDopaminergic NeuronsExonsGene ExpressionMiceReceptors, Dopamine D1RNA, MessengerDinoprostoneDopamineMisoprostolReceptors, Dopamine D1RNA, Messenger

Identifiers

PMID35177825
PMCPMC10009708
OpenAlexW4212858161

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.